Forging a path to more convenient and accessible healthcare
Vaxess is transforming delivery and accessibility of next-gen therapies
Vaxess is developing a novel microarray patch (MAP) platform capable of delivering a wide range of therapies.
Using the skin as a delivery pathway, Vaxess’s temperature stable, microarray patch MAP patch features dissolvable tips made from advanced biomaterials—enabling the greatest levels of dose delivery and control without the pain and hassle of an injection.
Vaxess is transforming the delivery of next-gen therapies, such as GLP-1.
Working Towards a Radically More Convenient, Patient-friendly Experience
Vaxess is mapping out a future where treatments are easier to use and available wherever patients are. At Vaxess, we envision a future where receiving therapies is dramatically more convenient, comfortable and aligned with everyday life. By removing sharps and eliminating the need for refrigeration, our MAP platform enables therapeutics to be self-administered in the comfort of a patient’s own home, on the go or while traveling.
Vaxess’s focus on the patient experience, combined with innovative engineering and design, will offer patients the option to receive novel, effective therapies – which would otherwise require injection – in a radically more convenient, pain-free way. It is incredibly motivating and inspiring to work towards impacting health at a truly global scale.”
- Rachel Sha, Vaxess CEO